SynthesisMedicina (Kaunas, Lithuania)2019

Which Should Be Used First for ALK-Positive Non-Small-Cell Lung Cancer: Chemotherapy or Targeted Therapy? A Meta-Analysis of Five Randomized Trials.

Yen-Chien Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.